Lin Zhang

Lin Zhang


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2024 in BMC Geriatrics
Verified
Journal Article
Open access
PDF file
YYYuan Yuan
Yuan Yuan
YYYong Yang
Yong Yang
XHXiaoFei Hu
XiaoFei Hu
LZLin Zhang
Lin Zhang
ZXZhiyu Xiong
Zhiyu Xiong
FXFeng Xu
Feng Xu
Objective: Research the dose–response relationship between overall and certain types of exercise and cognitive function in older adults with Alzheimer's disease and dementia. Design: Systemic and Bayesian Model-Based Network Meta-Analysis. Methods: In our study, we analyzed data from randomized controlled trials investigating the effects of different exercises on cognitive outcomes in older adults with AD. We searched the Web of Science, PubMed, Cochrane Central Register of Controlled Trials, and Embase up to November 2023. Using the Cochrane Risk of Bias tool (Rob2) for quality assessment and R software with the MBNMA package for data analysis, we determined standard mean differences (SMDs) and 95% confidence intervals (95%CrI) to evaluate exercise's impact on cognitive function in AD. Results: Twenty-seven studies with 2,242 AD patients revealed a nonlinear relationship between exercise and cognitive improvement in AD patients. We observed significant cognitive enhancements at an effective exercise dose of up to 1000 METs-min/week (SMDs: 0.535, SD: 0.269, 95% CrI: 0.023 to 1.092). The optimal dose was found to be 650 METs-min/week (SMDs: 0.691, SD: 0.169, 95% CrI: 0.373 to 1.039), with AE (Aerobic exercise) being particularly effective. For AE, the optimal cognitive enhancement dose was determined to be 660 METs-min/week (SMDs: 0.909, SD: 0.219, 95% CrI: 0.495 to 1.362). Conclusion: Nonlinear dose–response relationship between exercise and cognitive improvement in Alzheimer’s disease, with the optimal AE dose identified at 660 METs-min/week for enhancing cognitive function in AD.

3 June 2025 in Journal of Medical Internet Research
Verified
Journal Article
Open access
JDJiejie Dou
Jiejie Dou
JWJunyu Wang
Junyu Wang
XGXianqi Gao
Xianqi Gao
GWGuotuan Wang
Guotuan Wang
YBYing Bai
Ying Bai
LZLin Zhang
Lin Zhang
Background: Parkinson disease (PD) presents motor and nonmotor challenges that significantly affect quality of life. Telemedicine has emerged as a promising approach to deliver interventions, including exercise performed through remote equipment (e-Exercise), cognitive behavioral training sessions conducted remotely (e-Cognitive), and consultations conducted through remote devices (e-Visits), yet their comparative effectiveness remains unclear. Objective: This paper aimed to evaluate the effectiveness of telemedicine interventions on motor and nonmotor outcomes in PD and compare the efficacy of e-Exercise, e-Cognitive, and e-Visits. Methods: A systematic review and network meta-analysis were conducted by searching PubMed, MEDLINE, Embase, Cochrane CENTRAL, and Web of Science through November 2024. Randomized controlled trials comparing telemedicine interventions with usual care were included. Outcomes assessed included total motor symptoms, quality of life, cognitive function, depressive and anxiety symptoms, fear of falling, 6-minute walk test, walking velocity, balance ability, and timed up and go. Two investigators independently performed study selection, data extraction, and risk-of-bias assessment using the Cochrane risk of bias 2 tool. Data synthesis included (1) pairwise meta-analyses using random-effects models to calculate standardized mean differences (SMDs) and mean differences; and (2) Bayesian network meta-analysis integrating direct and indirect comparisons to rank intervention efficacy, with transitivity and inconsistency evaluated. Evidence quality was graded using GRADE (Grading of Recommendations, Assessment, Development and Evaluation), incorporating risk of bias, heterogeneity (I²>50% indicating substantial heterogeneity), precision, and publication bias (Egger test). Statistical heterogeneity was quantified by τ² and I². Results: A total of 23 studies involving 1330 participants were included. Pairwise meta-analyses demonstrated that telemedicine significantly improved total motor symptoms (SMD=–0.61, 95% CI –1.19 to –0.4), cognitive function (SMD=0.58, 95% CI 0.15-1.01), depressive symptoms (SMD=–0.46, 95% CI –0.88 to –0.04), anxiety symptoms (SMD=–0.57, 95% CI –1.10 to –0.03), fear of falling (SMD=–0.48, 95% CI –0.77 to –0.19), and 6-minute walk test performance (mean difference=18.98, 95% CI 16.06-21.90 meters). The network meta-analysis revealed that e-Exercise was most effective for improving total motor symptoms (SMD=–1.01, 95% credible interval [CrI] –1.96 to –0.05) and 6-minute walk test performance. e-Cognitive was most effective for enhancing quality of life (SMD=0.39, 95% CrI 0.06-0.73) and cognitive function (SMD=1.02, 95% CrI 0.38-1.66), and reducing depressive (SMD=–1.28, 95% CrI –1.61 to –0.96) and anxiety symptoms (SMD=–1.07, 95% CrI –1.40 to –0.75). e-Visits had a limited impact across outcomes. Evidence quality was moderate or high for motor symptoms, quality of life, and depression, but low or very low for other outcomes. Conclusions: Telemedicine is effective for improving motor and nonmotor outcomes in PD. e-Exercise is optimal for motor function and physical performance, while e-Cognitive is most effective for psychological and cognitive challenges. These findings highlight the importance of tailoring telemedicine programs to address specific therapeutic needs in PD management. Trial Registration: PROSPERO CRD42024628687; https://www.crd.york.ac.uk/PROSPERO/view/CRD42024628687

28 November 2025 in BMC Geriatrics
Verified
Journal Article
Open access
PDF file
ZXZhiyu Xiong
Zhiyu Xiong
YYYuan Yuan
Yuan Yuan
BQBopeng Qiu
Bopeng Qiu
YYYong Yang
Yong Yang
YBYing Bai
Ying Bai
LZLin Zhang
Lin Zhang
Sleep quality decreased can result in a major health issue in older people with age. While not all sleep changes are pathological in older people’s l

8 December 2025 in Frontiers in Physiology
Verified
Journal Article
Open access
PDF file
YLYiqi Li
Yiqi Li
YYYuan Yuan
Yuan Yuan
LHLijun Hua
Lijun Hua
LRLinghua Ran
Linghua Ran
BQBopeng Qiu
Bopeng Qiu
LZLin Zhang
Lin Zhang
Background: Fibromyalgia syndrome (FMS) is a chronic disorder marked by widespread pain. While aerobic exercise (AE) is widely recommended, its isolated effect and the optimal regimen and dose remain unclear. This study aimed to clarify the independent effect of pure AE on pain in FMS and identify the most effective exercise parameters and dose-response relationship. Methods: We systematically searched PubMed, Cochrane, Embase, and Web of Science up to June 2025 for randomized controlled trials (RCTs) examining AE’s effect on FMS pain. Subgroup analyses were performed by age, baseline pain level, exercise type, and protocol characteristics. Standardized mean differences (SMD) with 95% confidence intervals (CIs) were calculated, and dose–response relationships were explored. Results: Fourteen RCTs with 777 participants were included. AE significantly reduced pain compared with controls [SMD = −1.07; 95% CI: −1.57 to −0.57], especially in patients aged 45–60 years and those with chronic severe pain. The most effective intervention was moderate-intensity, water-based AE performed for 60 min per session, 1–2 times weekly, over 12–16 weeks. Dose–response analysis identified an optimal dose of 470 MET-min/week [SMD = −1.71; 95% CrI: −1.90 to −1.14], with an effective range of 75–750 MET-min/week. Conclusion: This meta-analysis confirms the efficacy of AE in reducing pain in FMS. AE significantly alleviates pain in fibromyalgia, with moderate-intensity, water-based, showing the most effective results. These findings provide strong evidence for incorporating AE as a key non-pharmacological strategy in the management of fibromyalgia, especially for patients with more severe pain. The identified optimal exercise parameters offer clear guidance for clinical practice, supporting the use of tailored exercise regimens in patient care. Systematic Review Registration: https://www.crd.york.ac.uk/PROSPERO/view/ , identifier CRD420251086595.

22 July 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
ZWZe Wang
Ze Wang
JWJirong Wang
Jirong Wang
JMJian Ma
Jian Ma
TCTianyi Chen
Tianyi Chen
HYHaoxuan Yang
Haoxuan Yang
LZLin Zhang
Lin Zhang
This study investigated the effects of swimmers’ character strengths (CS) on athletic performance and examined multiple mediating effects of psychological stress (PS), future self-continuity (FSC), and self-efficacy (SE) to reveal how psychological traits influence performance. Professional swimmers (n = 603, M = 374, F = 229, age = 18.07 ± 3.43) were assessed using the Future Self Continuity Scale, Chinese Virtues Questionnaire, General Self-Efficacy Scale, and Athlete Stress Evaluation Scale. Pearson tests and Structural Equation Modeling (SEM) examined correlations and mediation. Athlete level correlated positively with CS, SE, FSC dimensions (affinity, vitality, willpower) and challenge appraisal, and negatively with threat and injury appraisal. Athletic performance was positively associated with CS, FSC, SE, and challenge appraisal (r = 0.024–0.562, p < 0.05) and negatively with threat and injury appraisal (r = -0.501 to -0.036, p < 0.01). Mediation analysis revealed six pathways: affinity influenced performance via SE (indirect effect = 0.030, direct effect = 0.070, proportion = 29.99%), vitality via SE (0.033, 0.073, 31.03%), willpower via SE (0.034, 0.096, 25.90%), challenge appraisal via FSC (0.027, 0.090, 23.31%), threat appraisal via FSC (-0.014, -0.063, 18.71%), and injury appraisal via FSC (-0.022, -0.078, 22.14%). Affinity, vitality, and willpower increase with performance. CS positively predicts performance. PS predicts performance bidirectionally. SE and FSC mediate effects between CS, PS, and performance.

28 April 2025 in Frontiers in Endocrinology
Verified
Journal Article
Open access
PDF file
LZLin Zhang
Lin Zhang
XCXing Cheng
Xing Cheng
YYYong Yang
Yong Yang
XLXue Li
Xue Li
YYYuan Yuan
Yuan Yuan
Aims: This study aims to assess the effects of different exercise types and their specific doses on glycemic control among individuals with prediabetes.Methods: Multiple databases were subjected to a comprehensive search for randomized controlled trials (RCTs) published until 15 July 2024. The study protocol was prospectively registered with PROSPERO (CRD42024573186). The exercise interventions analyzed included aerobic exercise (AE), resistance training (RT), and combined aerobic–resistance training (AE+RT). Outcomes were quantified using standardized mean difference (SMD) with 95% credible intervals (CrIs), employing the confidence in network meta-analysis (CINeMA) framework for network meta-analysis to confirm the outcome reliability.Results: According to the network meta-analysis, irrespective of dose, AE+RT led to the largest decrease in fasting blood glucose (FBG) (−0.44, [−0.62 to −0.26]). AE alone resulted in the largest reductions in 2-hour post-meal blood glucose (2hPG) (−0.71, [−0.97 to −0.45]) and glycosylated hemoglobin A1c (HbA1c) (−0.30, [−0.37 to −0.22]). Dose–response (DR) analysis identified optimal doses for each exercise type: 880 metabolic equivalent of task minutes per week (METs-min/week) for both AE and RT and 800 METs-min/week for AE+RT to reduce FBG. The optimal dose for 2hPG improvement via AE was 1,100 METs-min/week, and for HbA1c reduction via RT, it was 870 METs-min/week.Conclusions: Given the variety of impaired glucose regulation (IGR), we recommend that people with prediabetes engage in RT at 1,100 METs-min/week to improve 2hPG and at 870 METs-min/week to reduce HbA1c. For FBG control, a dose of 800 METs-min/week is optimal for all exercise modalities. These evidence-based recommendations provide practical guidance for designing personalized exercise prescriptions to manage prediabetes.